The Janus face of Selinexor (KPT-330) in bacterial infection: short-term protection versus long-term lethality
Yan, Q.; Guo, L.; Sun, Q.
Show abstract
The clinical application of the anti-cancer drug KPT-330 (Selinexor) has been associated with increased infection-related mortality, yet its direct impact on infection pathogenesis remains unclear. Here, we found that KPT-330 treatment reduced host survival from 66% to 22% in a mouse model of bacterial pneumonia. Interestingly, KPT-330 conferred transient lung protection at 24 h post infection by blocking the nuclear export of I{kappa}B, suppressing NF{kappa}B signaling and immune cell recruitment. Meanwhile, KPT-330 induced apoptosis of lung epithelial cells, enhancing bacterial adhesions and invasion, and leading to dramatically increased bacterial load. These effects culminated in a compensatory immune rebound and more severe lung injury at later stages. Adjunctive therapy with the antibiotic polymyxin E (colistin) rescued survival, whereas the immunosuppressant dexamethasone did not, underscoring that timely bacterial clearance is critical for managing this adverse effect. Our findings provide direct evidence that KPT-330 exacerbates bacterial infection and advocate for an adjunctive antimicrobial prophylaxis strategy to ensure its safer use, especially in high-risk patients.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARS-CoV-2-Triggered Mast Cell Rapid Degranulation Induces Alveolar Epithelial Inflammation and Lung Injury 96%
- Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development 92%
- Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks 91%
Similar papers in this journal
- A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases 95%
- 12-Lipoxygenase (12-LOX) Plays a Key Role in Hyperinflammatory Response Caused by SARS-CoV-2 93%
- GP96 drives exacerbation of secondary bacterial pneumonia following influenza A virus infection 92%
Similar papers in this journal
- Vascular Endothelial-derived SPARCL1 Exacerbates Viral Pneumonia Through Pro-Inflammatory Macrophage Activation 94%
- Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates lung injury during mechanical ventilation 93%
- Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma. 93%
Similar papers in this journal
- Vaccination-induced rapid protection against bacterial pneumonia via training alveolar macrophage in mice 93%
- Hypothermia protects against ventilator-induced lung injury by limiting IL-1β release and NETs formation 93%
- A systematic CRISPR screen reveals an IL-20/IL20RA-mediated peritoneal immune crosstalk to prevent the ovarian cancer metastasis 93%
Similar papers in this journal
- The natural compound Notopterol targets JAK2/3 to ameliorate macrophage-induced inflammation and arthritis 92%
- Single-cell and spatial transcriptomics reveal the pathogenesis of chronic granulomatous disease in a natural model 92%
- Host-derived lipids from tuberculous pleurisy impair macrophage microbicidal-associated metabolic activity 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.